Related references
Note: Only part of the references are listed.Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjogren's syndrome: Findings from the NIH cohort
M. Billings et al.
ORAL DISEASES (2018)
Management of primary Sjogren's syndrome: recent developments and new classification criteria
Nicoletta Del Papa et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2018)
Reviewing primary Sjogren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
Tim Both et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome
Kendrick Co Shih et al.
JOURNAL OF INFLAMMATION-LONDON (2017)
First Pediatric Patient With Neuromyelitis Optica and Sjögren Syndrome Successfully Treated With Tocilizumab
Achille Marino et al.
PEDIATRIC NEUROLOGY (2017)
Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjogren's Syndrome
Simon J. Bowman et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjogren's Syndrome
Gwenny M. Verstappen et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Sjogren's syndrome from the perspective of ophthalmology
Eric Kuklinski et al.
CLINICAL IMMUNOLOGY (2017)
Primary Sjogren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy
J. Demarchi et al.
CLINICAL RHEUMATOLOGY (2017)
Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis
Shi-Qin Wang et al.
BMC MUSCULOSKELETAL DISORDERS (2017)
A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjogren's syndrome
Claudia Kedor et al.
CLINICAL RHEUMATOLOGY (2016)
Treatment of primary Sjogren syndrome
Alain Saraux et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Use of Biologics in Sjogren's Syndrome
Gaetane Nocturne et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren's syndrome
Alan N. Baer et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study
Xavier Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Efficacy and safety of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjogren's syndrome Endocrinopathy (ROSE) trial an open-label, one-year, prospective study Interim analysis of 32 patients for 24 weeks
Hiroto Tsuboi et al.
MODERN RHEUMATOLOGY (2015)
Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sjogren Syndrome
Tetsuya Kawakita et al.
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY (2015)
Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort
Astrid Rasmussen et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Sjogren's syndrome: Where do we stand, and where shall we go?
Divi Cornec et al.
JOURNAL OF AUTOIMMUNITY (2014)
Diagnosis of Sjogren's Syndrome American-European and the American College of Rheumatology Classification Criteria
Vidya Sankar et al.
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA (2014)
CD22 ligation inhibits downstream B cell receptor signaling and Ca2+flux upon activation
N. Sieger et al.
ARTHRITIS AND RHEUMATISM (2013)
Novel aspects of Sjogren's syndrome in 2012
Angela Tincani et al.
BMC MEDICINE (2013)
Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry
A. Mekinian et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
American College of Rheumatology classification criteria for Sjogren's syndrome: A data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance Cohort
S. C. Shiboski et al.
ARTHRITIS CARE & RESEARCH (2012)
Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome
An-Ping Huo et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2010)
Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Epratuzumab (humanised anti-CD22 antibody) in primary Sjogren's syndrome: an open-label phase I/II study
Serge D. Steinfeld et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Inefficacy of infliximab in primary Sjogren's syndrome -: Results of the randomized, controlled trial of Remicade in primary Sjogren's syndrome (TRIPSS)
X Mariette et al.
ARTHRITIS AND RHEUMATISM (2004)
Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: A randomized, double-blind clinical study
M Ono et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca
D Petrone et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
